cp wire

CP Wire Articles

$1.3 Billion Merger Between Akebia Therapeutics and Keryx Biopharmaceuticals to Focus on Kidney Disease
  • Combined company will be named Akebia Therapeutics, Inc.
  • Company will focus on patients with chronic kidney disease
  • Combined portfolio can address the needs of an estimated... read more
Thu, 06/28/18 - 09:17 am
Cedilla Therapeutics Adds Three Veterans to Enhance Discovery

Cedilla Therapeutics  announced on 6/28/2018 the appointment of three vice presidents with extensive experience in drug discovery to advance the company’s mission of harnessing existing protein... read more

Thu, 06/28/18 - 09:05 am
Microbiome report for week ending 6-24-18

Some important/interesting microbiome related news for the week ending 6-24-18:

Axial Biotherapeutics and the... read more

Wed, 06/27/18 - 07:51 pm
FDA Grants Orphan Drug Status for Cannabidiol in the Treatment of Autoimmune Hepatitis

Revive Therapeutics Ltd. (TSX VENTURE:RVV) (OTCQB:RVVTF) announcedon 6/27/2018 that the U.S. Food and Drug Administration (“FDA”) has granted orphan drug designation for cannabidiol (“CBD”) in the... read more

Wed, 06/27/18 - 10:07 am
FDA Grants Priority Review for Pfizer’s Glasdegib in Acute Myeloid Leukemia
  • Glasdegib combined with chemotherapy almost doubled overall survival compared to chemotherapy alone
  • PDUFA goal date is set in December of 2018
  • Ph III trials began enrolling... read more
Wed, 06/27/18 - 09:49 am

Pages